May 8, 2024 4:30pm EDT SCYNEXIS Reports First Quarter 2024 Financial ResultsĀ and Provides Corporate Update
Apr 30, 2024 4:05pm EDT SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)